Kutatási jelek – Signal Engine

• Charting the future of esophageal cancer translation: insights from clinical trial landscape — Esophageal cancer
• Immunotherapy for Paediatric Diffuse Large B-Cell Lymphoma: A Review of Current Clinical Trials and Future Directions — Diffuse large B-cell lymphoma
• Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics — Waldenstrom macroglobulinemia
• Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma — Neuroblastoma
• Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches — NSCLC
• Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics‑based liquid biopsy assay — Renal cell carcinoma
• Selective Elimination of Breast Surgery for Invasive Breast Cancer — Breast cancer
• Amivantamab Monotherapy in Chemorefractory RAS / BRAF Wild‑Type Metastatic Colorectal Cancer: Results From OrigAMI‑1, an Open‑Label, Phase Ib/II Study — Colorectal cancer
• Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors — Colorectal cancer
• Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUST — NSCLC
• Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort — Hepatocellular carcinoma
• Therapy for Stage IV Non‑Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0 — NSCLC
• Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD‑L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single‑arm, phase 2 study — NSCLC
• Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma — Hepatocellular carcinoma
• Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group — Prostate cancer
• Real-World Epidemiology, Treatment Patterns, and Outcomes of Hepatocellular Carcinoma in Brazil: A Multicenter Retrospective Study — Hepatocellular carcinoma
• The contemporary management of prostate cancer — Prostate cancer
• Ribociclib Plus Endocrine Therapy in Hormone Receptor‑Positive/ERBB2‑Negative Early Breast Cancer: 4‑Year Outcomes From the NATALEE Randomized Clinical Trial — Breast cancer
• Osimertinib Dose Optimization Guided by Therapeutic Drug Monitoring in Patients With EGFR-Mutated Advanced Non‑Small Cell Lung Cancer: A Case series — NSCLC
• CD151 Promotes Cancer Progression in Triple‑Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway — Breast cancer